Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression. 2005

Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
Institut de Recherche pour le Développement (IRD), UR34 Maladies Virales Emergentes, Laboratoire d'Immunologie Rétrovirale et Moléculaire; 240, Av. Emile Jeanbrau, EFS, 34094 Montpellier, France.

OBJECTIVE The soluble HIV-1 gp120 envelope glycoprotein, after being shed from infected cells, can cross-link its receptors on both HIV-1 infected and non-infected target cells, leading to their activation. We have assessed the impact of soluble gp120 on viral replication in CD4+/CXCR4+ T cells, via its effects on Tat-mediated transactivation of the HIV-1/LTR. METHODS Primary cord blood-derived CD4+/CXCR4+ T cells were stimulated with soluble recombinant gp120 (rgp120) from the HIV-1/HXB2 clone. The level of gene or protein expression was assessed by serial analysis gene expression (SAGE), reverse transcriptase-polymerase chain reaction, western blotting or flow-cytometry analysis. Cellular division of rgp120-stimulated T cells was assessed by CFDA-SE labeling. Long terminal repeat (LTR) activity and HIV infection level were respectively measured by a chemiluminescent beta-gal Reporter Gene Assay and by p24 determination. RESULTS We have demonstrated that rgp120 activates both PKCepsilon and its upstream effector PI3K/Akt, involved in the HIV-1 replication process. Moreover, rgp120 enhances the gene, as well as protein expression of the cellular Tat cofactors Tat-Sf1 and SPT5 in primary CD4+/CXCR4+ T cells. Finally, stimulation of HIV-1 infected T cells with rgp120 was found to result in both a higher LTR-activity and an increased production of viral particles. CONCLUSIONS Taken together, these results show that soluble gp120 contributes to HIV-1 replication and dissemination, via the activation of multiple cell signaling pathways and the induction of Tat-cofactor expression, underscoring its potential as a therapeutic target in HIV-1-mediated pathogenesis.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
November 2012, Virology journal,
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
June 1995, Nature,
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
December 2000, Proceedings of the National Academy of Sciences of the United States of America,
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
January 2020, Frontiers in immunology,
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
May 2002, Journal of acquired immune deficiency syndromes (1999),
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
January 2012, PloS one,
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
January 2012, PloS one,
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
January 2003, Biochemical and biophysical research communications,
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
December 2003, Journal of leukocyte biology,
Dorothée Missé, and Johanna Gajardo, and Christelle Oblet, and Agniezska Religa, and Nathalie Riquet, and Danièle Mathieu, and Hans Yssel, and Francisco Veas
March 1998, Human gene therapy,
Copied contents to your clipboard!